The prognostic significance of high/positive expression of tissue VEGF in ovarian cancer

Bing-Qin Guo; Wen-Qiao Lu

doi:10.18632/oncotarget.25702

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

The prognostic significance of high/positive expression of tissue VEGF in ovarian cancer

Bing-Qin Guo and Wen-Qiao Lu _

PDF | HTML | How to cite

Oncotarget. 2018; 9:30552-30560. https://doi.org/10.18632/oncotarget.25702

Metrics: PDF 1214 views | HTML 1903 views | ?

Abstract

Bing-Qin Guo1 and Wen-Qiao Lu2

1Department of Pathology, The First Affiliated Hospital of Bengbu Medical College, Anhui 233003, China

2The Interventional Diagnosis and Treatment Ward, Thoracic Hospital in Shandong Province, Shandong 250013, China

Correspondence to:

Wen-Qiao Lu, email: [email protected]

Keywords: VEGF; ovarian cancer; prognosis

Received: January 19, 2018 Accepted: May 21, 2018 Published: July 17, 2018

ABSTRACT

Background & aim: At present, numerous reports have shown that high/positive expression of tissue vascular endothelial growth factor (VEGF) may be associated with the prognosis of patients with ovarian cancer. However, their results still remained controversy. Thus, this meta-analysis was designed to analyze and assess the prognostic value of tissue VEGF expression in patients with ovarian cancer.

Method: We searched PubMed, Embase, Cochrane Library and Web of Science to October, 2017. Hazard Ratio (HR) with its 95% confidence intervals (CIs) was used to evaluate the association between high/positive expression of tissue VEGF and the prognosis of ovarian cancer patients. All statistical analyses were performed using standard statistical procedures provided in RevMan 5.2.

Result: A total of 18 studies (including 1145 patients) were included for this meta-analysis. The positive/high expression of tissue VEGF had an obvious association with overall survival (OS) (HR 2.24, 95% CI 1.36–3.70; P=0.002), progression-free survival (PFS) (HR 1.60, 95% CI 1.11–2.31; P=0.01) and disease-free survival (DFS) (HR 3.49, 95% CI 1.27–9.56; P=0.02) of patients with ovarian cancer respectively.

Conclusion: The present meta-analysis indicated that positive/high expression of tissue VEGF may have a close association with survival of ovarian cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25702

Publication Alerts

Research Papers:

The prognostic significance of high/positive expression of tissue VEGF in ovarian cancer

Abstract